List of Tables
Table 1. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competitive Situation by Manufacturers in 2022
Table 4. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Non-steroidal Anti-inflammatory Drugs (NSAID), Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID), Product Type & Application
Table 12. Global Key Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-steroidal Anti-inflammatory Drugs (NSAID) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-steroidal Anti-inflammatory Drugs (NSAID) as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2018-2023) & (K Units)
Table 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2018-2023)
Table 19. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2024-2029) & (K Units)
Table 20. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2024-2029)
Table 21. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2018-2023)
Table 23. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2024-2029)
Table 25. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2018-2023) & (K Units)
Table 27. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2024-2029) & (K Units)
Table 28. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2018-2023) & (K Units)
Table 32. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2024-2029) & (K Units)
Table 33. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Type (2018-2023)
Table 51. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Type (2024-2029)
Table 52. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2018-2023)
Table 53. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2024-2029)
Table 54. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2018-2023)
Table 57. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2024-2029)
Table 58. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Type (2018-2023)
Table 59. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Type (2024-2029)
Table 60. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Application (2018-2023)
Table 61. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Application (2024-2029)
Table 62. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2018-2023)
Table 63. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2024-2029)
Table 64. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2018-2023)
Table 67. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2024-2029)
Table 68. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Application (2018-2023)
Table 69. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Application (2024-2029)
Table 70. Bayer Corporation Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 74. Bayer Recent Developments/Updates
Table 75. Ecotrin Corporation Information
Table 76. Ecotrin Description and Business Overview
Table 77. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 79. Ecotrin Recent Developments/Updates
Table 80. Generic Corporation Information
Table 81. Generic Description and Business Overview
Table 82. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 84. Generic Recent Developments/Updates
Table 85. St. Joseph Corporation Information
Table 86. St. Joseph Description and Business Overview
Table 87. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 89. St. Joseph Recent Developments/Updates
Table 90. Elanco Corporation Information
Table 91. Elanco Description and Business Overview
Table 92. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 94. Elanco Recent Developments/Updates
Table 95. Zoetis Corporation Information
Table 96. Zoetis Description and Business Overview
Table 97. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 99. Zoetis Recent Developments/Updates
Table 100. Boehringer Ingelheim Corporation Information
Table 101. Boehringer Ingelheim Description and Business Overview
Table 102. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 104. Boehringer Ingelheim Recent Developments/Updates
Table 105. Merial Corporation Information
Table 106. Merial Description and Business Overview
Table 107. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 109. Merial Recent Developments/Updates
Table 110. Merck Animal Health Corporation Information
Table 111. Merck Animal Health Description and Business Overview
Table 112. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product
Table 114. Merck Animal Health Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors List
Table 118. Non-steroidal Anti-inflammatory Drugs (NSAID) Customers List
Table 119. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Trends
Table 120. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers
Table 121. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Challenges
Table 122. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Non-steroidal Anti-inflammatory Drugs (NSAID)
Figure 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Type in 2022 & 2029
Figure 4. Salicylates Product Picture
Figure 5. Propionic acid derivatives Product Picture
Figure 6. Acetic acid derivatives Product Picture
Figure 7. Enolic acid (Oxicam) derivatives Product Picture
Figure 8. Anthranilic acid derivatives (Fenamates) Product Picture
Figure 9. Selective COX-2 inhibitors (Coxibs) Product Picture
Figure 10. Sulfonanilides Product Picture
Figure 11. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 12. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Application in 2022 & 2029
Figure 13. Human
Figure 14. Animals
Figure 15. Others
Figure 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size (2018-2029) & (US$ Million)
Figure 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (2018-2029) & (K Units)
Figure 19. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price (USD/Unit) & (2018-2029)
Figure 20. Non-steroidal Anti-inflammatory Drugs (NSAID) Report Years Considered
Figure 21. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Manufacturers in 2022
Figure 22. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers in 2022
Figure 23. The Global 5 and 10 Largest Non-steroidal Anti-inflammatory Drugs (NSAID) Players: Market Share by Revenue in 2022
Figure 24. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 25. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 26. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2018-2029)
Figure 27. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2018-2029)
Figure 28. U.S. Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2018-2029)
Figure 31. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2018-2029)
Figure 32. Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. France Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. U.K. Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2018-2029)
Figure 38. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2018-2029)
Figure 39. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Australia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Taiwan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Indonesia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Thailand Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Malaysia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Philippines Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2018-2029)
Figure 50. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2018-2029)
Figure 51. Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2018-2029)
Figure 55. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. U.A.E Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2018-2029)
Figure 60. Global Revenue Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2018-2029)
Figure 61. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Type (2018-2029)
Figure 62. Global Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application (2018-2029)
Figure 63. Global Revenue Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application (2018-2029)
Figure 64. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Application (2018-2029)
Figure 65. Non-steroidal Anti-inflammatory Drugs (NSAID) Value Chain
Figure 66. Non-steroidal Anti-inflammatory Drugs (NSAID) Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed